1,6-bis(cyclohexyloximinocarbonyl)hexane has been researched along with Adenocarcinoma in 1 studies
1,6-bis(cyclohexyloximinocarbonyl)hexane: selective inhibitor of canine platelet diglyceride lipase
Adenocarcinoma: A malignant epithelial tumor with a glandular organization.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wasilewski, A | 1 |
| Krajewska, U | 1 |
| Owczarek, K | 1 |
| Lewandowska, U | 1 |
| Fichna, J | 1 |
1 other study available for 1,6-bis(cyclohexyloximinocarbonyl)hexane and Adenocarcinoma
| Article | Year |
|---|---|
Fatty acid amide hydrolase (FAAH) inhibitor PF-3845 reduces viability, migration and invasiveness of human colon adenocarcinoma Colo-205 cell line: an in vitro study.
Topics: Adenocarcinoma; Amidohydrolases; Antineoplastic Agents; Benzodioxoles; Cell Line, Tumor; Cell Moveme | 2017 |